In life sciences, a pitch has to carry more weight than most. It has to explain the science, establish credibility, frame the market, clarify the development path, and make the opportunity feel de-risked. But founders often approach that task from different starting points. Science-led founders tend to begin with the

An effective biotech pitch deck, or corporate slide deck, needs to sell both your science and your company to potential investors. To help you craft a clear, persuasive deck that delivers results, we’re sharing a series of proven Theoria Creative strategies and templates as a guide. This article is part

There’s a moment most biotech founders know well. The science is solid. The team is credible. The data is strong. And yet, somewhere between the pitch deck and the term sheet, something breaks down. In 2020 we had an oncology company client with a strong scientific platform, five first-in-class programs,

Reflecting on 2025, the biotech industry considerably advanced in gene editing, oncology, and AI-driven drug discovery and saw increased M&A activity. We also witnessed a notable shift from oncology innovations beginning to influence treatments in immunology and autoimmune diseases. As the year draws to a close, we’re proud to celebrate

An effective biotech pitch deck, or corporate slide deck, needs to sell both your science and your company to potential investors. To help you craft a clear, persuasive deck that delivers results, we’re sharing a series of proven Theoria Creative strategies and templates as a guide. This article is part

An effective biotech pitch deck, or corporate slide deck, needs to sell both your science and your company to potential investors. To help you craft a clear, persuasive deck that delivers results, we’re sharing a series of proven Theoria Creative strategies and templates as a guide. This article is part